๐ฌ GLP-1s being tested for cancer and metabolic issues
Researchers are actively exploring the use of GLP-1 agonists in various medical fields. This investigation involves multiple international programs focusing on new therapeutic applications. The trials are looking at their potential for treating blood cancer and preventing metabolic diseases. These compounds show promise due to their effects on glucose regulation and inflammation. Further research will determine the long-term efficacy and safety profile of these treatments.